Cancer

Showing NaN - NaN of 104

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer Trial in Nashville (Educational Intervention, Follow-Up Care, Psychosocial Assessment and Care)

Terminated
  • Cancer
  • Educational Intervention
  • +3 more
  • Nashville, Tennessee
  • +1 more
Oct 15, 2019

Cancer Trial in United States (LYC-55716)

Completed
  • Cancer
  • Huntsville, Alabama
  • +19 more
Sep 24, 2019

Cancer Trial in Nashville (IHL-305 (irinotecan liposome injection))

Completed
  • Cancer
  • IHL-305 (irinotecan liposome injection)
  • Nashville, Tennessee
  • +1 more
Jul 2, 2019

Cancer Trial in Australia, United States (GSK2118436, GSK1120212)

Completed
  • Cancer
  • Los Angeles, California
  • +14 more
Jun 25, 2019

Cancer Trial in United States (SC-004, ABBV-181)

Terminated
  • Cancer
  • Birmingham, Alabama
  • +11 more
May 10, 2019

Cancer Trial in Worldwide (GSK2118436, GSK1120212, Other approved anti-cancer agent)

Completed
  • Cancer
  • Goodyear, Arizona
  • +43 more
Mar 20, 2019

Cancer, Advanced Solid Malignancies Trial in Worldwide (AZD4547)

Terminated
  • Cancer
  • Advanced Solid Malignancies
  • Stanford, California
  • +28 more
Nov 30, 2018

Cancer Trial in Nashville (genetic, other, procedure)

Terminated
  • Cancer
  • DNA analysis
  • +6 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Aug 14, 2018

Cancer Trial in Korea, Republic of, United Kingdom, United States (GSK2636771)

Completed
  • Cancer
  • New Haven, Connecticut
  • +7 more
Jul 20, 2018

Cancer Trial in Boston, Nashville, Houston (Trametinib, Palbociclib)

Completed
  • Cancer
  • Boston, Massachusetts
  • +2 more
May 31, 2018

Cancer, Colon Cancer, Colorectal Cancer Trial in Worldwide (Pegfilgrastim, Placebo, Bevacizumab)

Completed
  • Cancer
  • +7 more
  • Muscle Shoals, Alabama
  • +153 more
Dec 5, 2017

Cancer Trial in Canada, United States (PTC596)

Completed
  • Cancer
  • Boston, Massachusetts
  • +3 more
Dec 6, 2017

Cancer Trial in United States (Regimen A, Regimen B, Regimen C)

Completed
  • Cancer
  • Regimen A
  • +3 more
  • Scottsdale, Arizona
  • +3 more
Nov 10, 2017

Cancer Trial in Australia, United Kingdom, United States (GSK2118436 75 mg, Placebo)

Completed
  • Cancer
  • GSK2118436 75 mg
  • Placebo
  • Scottsdale, Arizona
  • +7 more
Nov 8, 2017

Cancer Trial in United States (GSK1120212B (Standard DMSO content), GSK1120212B (Lower DMSO content))

Completed
  • Cancer
  • GSK1120212B (Standard DMSO content)
  • GSK1120212B (Lower DMSO content)
  • Goodyear, Arizona
  • +3 more
Nov 8, 2017

Cancer Trial in Worldwide (Trametinib (GSK1120212), Docetaxel, Erlotinib)

Completed
  • Cancer
  • Trametinib (GSK1120212)
  • +6 more
  • Scottsdale, Arizona
  • +19 more
Nov 8, 2017

Cancer Trial in Detroit, Nashville, San Antonio (GSK1120212)

Completed
  • Cancer
  • Detroit, Michigan
  • +2 more
Nov 8, 2017

Cancer Trial in United States (GSK1120212, GSK2141795)

Completed
  • Cancer
  • Aurora, Colorado
  • +9 more
Nov 8, 2017

Cancer Trial in Scottsdale, Nashville (Trametinib tablet, Trametinib pediatric formulation)

Completed
  • Cancer
  • Trametinib tablet
  • Trametinib pediatric formulation
  • Scottsdale, Arizona
  • +1 more
Nov 8, 2017

Cancer Trial in Canada, United States (GSK2141795)

Completed
  • Cancer
  • Baltimore, Maryland
  • +6 more
Nov 8, 2017

Cancer Trial in Australia, United States (GSK2118436, Midazolam)

Completed
  • Cancer
  • Los Angeles, California
  • +7 more
Nov 8, 2017

Cancer Trial in Nashville, San Antonio, Paris Cedex 20 (GSK1120212 plus everolimus)

Completed
  • Cancer
  • GSK1120212 plus everolimus
  • Nashville, Tennessee
  • +2 more
Nov 7, 2017

Cancer Trial in United States (FluMist, Placebo)

Completed
  • Cancer
  • FluMist
  • Placebo
  • Rochester, New York
  • +4 more
Jun 29, 2017